Effect of three fibrate derivatives and of two HMG-CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolemia

A. Branchi, A. Rovellini, D. Sommariva, A. G. Gugliandolo, A. Fasoli

Research output: Contribution to journalArticle

Abstract

In order to evaluate the effects of hypocholesterolemic drugs on plasma fibrinogen concentration, six groups of subjects with primary hypercholesterolemia have been put on treatment with diet alone or diet plus fenofibrate (100 mg t.i.d.), slow release bezafibrate (400 mg once a day), gemfibrozil (600 mg b.i.d.), simvastatin (20 mg once a day) or pravastatin (20 mg once a day) respectively. After 1 month of therapy, plasma fibrinogen significantly decreased by 9% and 15% in fenofibrate and bezafibrate groups respectively and increased by 19% in gemfibrozil treated patients. After 4 months of therapy the changes were -16% with fenofibrate, -10% with bezafibrate and +20% with gemfibrozil. No significant changes were observed in patients treated with diet alone, simvastatin or pravastatin. The fibrinogen lowering effect of fenofibrate and bezafibrate does not seem to be related to the hypolipidemic activity of the drugs.

Original languageEnglish
Pages (from-to)241-243
Number of pages3
JournalThrombosis and Haemostasis
Volume70
Issue number2
Publication statusPublished - 1993

Fingerprint

Bezafibrate
Fenofibrate
Fibric Acids
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Gemfibrozil
Hypercholesterolemia
Fibrinogen
Pravastatin
Simvastatin
Diet
Hypolipidemic Agents
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Hematology

Cite this

Effect of three fibrate derivatives and of two HMG-CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolemia. / Branchi, A.; Rovellini, A.; Sommariva, D.; Gugliandolo, A. G.; Fasoli, A.

In: Thrombosis and Haemostasis, Vol. 70, No. 2, 1993, p. 241-243.

Research output: Contribution to journalArticle

@article{9f8765ee17864d1c86f882c831f7bb3f,
title = "Effect of three fibrate derivatives and of two HMG-CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolemia",
abstract = "In order to evaluate the effects of hypocholesterolemic drugs on plasma fibrinogen concentration, six groups of subjects with primary hypercholesterolemia have been put on treatment with diet alone or diet plus fenofibrate (100 mg t.i.d.), slow release bezafibrate (400 mg once a day), gemfibrozil (600 mg b.i.d.), simvastatin (20 mg once a day) or pravastatin (20 mg once a day) respectively. After 1 month of therapy, plasma fibrinogen significantly decreased by 9{\%} and 15{\%} in fenofibrate and bezafibrate groups respectively and increased by 19{\%} in gemfibrozil treated patients. After 4 months of therapy the changes were -16{\%} with fenofibrate, -10{\%} with bezafibrate and +20{\%} with gemfibrozil. No significant changes were observed in patients treated with diet alone, simvastatin or pravastatin. The fibrinogen lowering effect of fenofibrate and bezafibrate does not seem to be related to the hypolipidemic activity of the drugs.",
author = "A. Branchi and A. Rovellini and D. Sommariva and Gugliandolo, {A. G.} and A. Fasoli",
year = "1993",
language = "English",
volume = "70",
pages = "241--243",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "2",

}

TY - JOUR

T1 - Effect of three fibrate derivatives and of two HMG-CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolemia

AU - Branchi, A.

AU - Rovellini, A.

AU - Sommariva, D.

AU - Gugliandolo, A. G.

AU - Fasoli, A.

PY - 1993

Y1 - 1993

N2 - In order to evaluate the effects of hypocholesterolemic drugs on plasma fibrinogen concentration, six groups of subjects with primary hypercholesterolemia have been put on treatment with diet alone or diet plus fenofibrate (100 mg t.i.d.), slow release bezafibrate (400 mg once a day), gemfibrozil (600 mg b.i.d.), simvastatin (20 mg once a day) or pravastatin (20 mg once a day) respectively. After 1 month of therapy, plasma fibrinogen significantly decreased by 9% and 15% in fenofibrate and bezafibrate groups respectively and increased by 19% in gemfibrozil treated patients. After 4 months of therapy the changes were -16% with fenofibrate, -10% with bezafibrate and +20% with gemfibrozil. No significant changes were observed in patients treated with diet alone, simvastatin or pravastatin. The fibrinogen lowering effect of fenofibrate and bezafibrate does not seem to be related to the hypolipidemic activity of the drugs.

AB - In order to evaluate the effects of hypocholesterolemic drugs on plasma fibrinogen concentration, six groups of subjects with primary hypercholesterolemia have been put on treatment with diet alone or diet plus fenofibrate (100 mg t.i.d.), slow release bezafibrate (400 mg once a day), gemfibrozil (600 mg b.i.d.), simvastatin (20 mg once a day) or pravastatin (20 mg once a day) respectively. After 1 month of therapy, plasma fibrinogen significantly decreased by 9% and 15% in fenofibrate and bezafibrate groups respectively and increased by 19% in gemfibrozil treated patients. After 4 months of therapy the changes were -16% with fenofibrate, -10% with bezafibrate and +20% with gemfibrozil. No significant changes were observed in patients treated with diet alone, simvastatin or pravastatin. The fibrinogen lowering effect of fenofibrate and bezafibrate does not seem to be related to the hypolipidemic activity of the drugs.

UR - http://www.scopus.com/inward/record.url?scp=0027282665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027282665&partnerID=8YFLogxK

M3 - Article

C2 - 8236126

AN - SCOPUS:0027282665

VL - 70

SP - 241

EP - 243

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 2

ER -